Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Liver Fibrosis: New Mechanisms, New Treatments, and Why They Matter

Dr. Wells will discuss the unapproved use of Fibroscan® and MR elastography. Liver fibrosis, like pathological fibrosis in other organs, has been termed "wound healing gone bad." Simply defined, it is...
CME credit is no longer available for this conference.

Course Authors

Rebecca G. Wells, M.D.

Dr. Wells is Assistant Professor of Medicine (Gastroenterology), University of Pennsylvania School of Medicine, Philadelphia, PA.

Dr. Wells reports no conflicts of interest.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss current thinking about the mechanisms of fibrosis

  • Discuss new modalities for diagnosing fibrosis

  • Discuss evidence supporting the possibility of fibrosis regression

  • Discuss new treatment options for fibrosis, and understand their relationship to concepts of regression.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity

Courses You Might Like

GI Manifestations of Covid-19

The coronavirus disease-2019 (COVID-19), the clinical name of the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection that originated in the city of Wuhan, province of Hubei in China, in December 2019, was declared a pandemic by the World Health Organization on March 11, 2020. At the beginning of May 2020, the Centers for Disease Control and Prevention (CDC) in the United States recognized the presence of ??oegastrointestinal symptoms, like nausea, vomiting and diarrhea, as less common symptoms??? of
Authors: Max Schmulson, M.D., R.F.F.
Estimated Time: 1 Hour
More

Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide and one of the leading causes of death in patients with cirrhosis. Despite improvements in treatment, patients with HCC continue to have a dismal prognosis, with 5-year survival rates of only 18%. This poor survival is related to under-recognition of at-risk patients and under-utilization of surveillance, with nearly two-thirds of tumors being diagnosed at advanced stages. Further, there is underuse of treatment in many
Authors: Brian C. Davis, M.D., and Amit G. Singal, M.D., M.S.
Estimated Time: 1 Hour
More

Pancreatic Adenocarcinoma

Although the 10th most common cause of cancer in the United States, pancreatic cancer continues to far outpace its incidence rate with respect to mortality. In 2011, an estimated 37,660 patients died of pancreatic cancer, making it the fourth most common cause of cancer death in men and women. The incidence and mortality rates have unfortunately remained almost unchanged for the past several decades. The majority of these tumors (85%) are adenocarcinomas arising from the ductal epithelium. In this presentation
Authors: Parvin Peddi, M.D., and Andrea Wang-Gillam, M.D.
Estimated Time: 1 Hour
More

The Indigenous Gastrointestinal Microbiota in Health and Disease

The gastrointestinal tract of mammals is inhabited by a complex microbial community. This community of microbes, referred to as the microbiota, has gained increased prominence of late. The traditional view of the microbiota regarded them as “commensal,” merely organisms that had found a ready source of food but did not contribute anything of value to their host. More recently, however, evidence has emerged that suggests that the microbiota can play key roles both in maintenance of health as well as
Authors: John Y. Kao, M.D., Nirmal Kaur, M.D., and Vincent B. Young M.D., Ph.D.
Estimated Time: 1 Hour
More

Chronic Pancreatitis: Diagnosis and Management

By far the most common etiology of chronic pancreatitis is alcohol abuse, estimated to cause 60-90% of the cases (Figure 1). Approximately 20% of the cases are classified as idiopathic. About 10% of the cases are caused by hereditary pancreatitis (a disorder resulting from mutations in trypsinogen), cystic fibrosis, hyperparathyroidism, hypertriglyceridemia, obstruction of the pancreatic duct, pancreatic divisum (a congenital abnormality of fusion of the ducts of the embryological ventral and dorsal pancreas), trauma, tropical pancreatitis and autoimmune pancreatitis. The
Authors: Stephen Pandol, M.D., and Hartley Cohen, M.D.
Estimated Time: 1 Hour
More

Acute Pancreatitis: Diagnosis and Management

Acute pancreatitis is a disorder primarily of the exocrine pancreas involving varying degrees of acute inflammation and parenchymal injury of the gland. In its most severe forms, there is a widespread inflammatory response involving organs both adjacent and distant from the pancreas; and the parenchymal injury is manifest as necrosis of pancreatic tissue. The clinical syndrome resulting from an episode of acute pancreatitis includes the rapid onset of abdominal pain with variable abdominal findings ranging from mild tenderness to peritoneal
Authors: Stephen J. Pandol M.D.
Estimated Time: 1 Hour
More